Breast Cancer Test (OncotypeDX)

News released today shows Breast Cancer Test – OncotypeDX – reduces the need for Chemotherapy.

ICORG was involved in this Global Clinical Trial associated with the development of this; nearly 700 Irish Patients took part at Hospitals throughout Ireland between 2007 – 2010.

Dr Janice Walshe was the Chief Investigator in Ireland. Click for the related news pieces on : RTE News and newstalk

MTCI Immunotherapy Forum

On Friday 23rd January [4pm – 7pm] in the Herbert Park Hotel, Ballsbridge, Dublin 4, MTCI are hosting a Translational Research Forum on "Successful, Immunotherapeutic approaches to treat Adjuvant, Occult disease in Carcinoma". The Guest Speakers are Dr. Michael G. Hanna, Ph.D. & Dr. Jan Vermorken, M.D., Ph.D.

RsqVD - New ICORG Blood Cancer Study

RsqVD is a new Clinical Trial in Multiple Myeloma that ICORG is operating through 8 Hospital Centres throughout Ireland and in conjugation with the Dana Farber Institute.
 
Click here for recent press coverage or here for further trial details